Wildhagen MF - Search Results

1

Screening for cystic fibrosis and its evaluation.

Wildhagen MF, ten Kate LP, Habbema JD. Wildhagen MF, et al. Br Med Bull. 1998;54(4):857-75. doi: 10.1093/oxfordjournals.bmb.a011734. Br Med Bull. 1998. PMID: 10367419 Review.

2

Cost of care of patients with cystic fibrosis in The Netherlands in 1990-1.

Wildhagen MF, Verheij JB, Verzijl JG, Hilderink HB, Kooij L, Tijmstra T, ten Kate LP, Gerritsen J, Bakker W, Habbema JD. Wildhagen MF, et al. Thorax. 1996 Mar;51(3):298-301. doi: 10.1136/thx.51.3.298. Thorax. 1996. PMID: 8779135 Free PMC article.

3

Comparison of single-entry and double-entry two-step couple screening for cystic fibrosis carriers.

ten Kate LP, Verheij JB, Wildhagen MF, Hilderink HB, Kooij L, Verzijl JG, Habbema JD. ten Kate LP, et al. Among authors: wildhagen mf. Hum Hered. 1996 Jan-Feb;46(1):20-5. doi: 10.1159/000154320. Hum Hered. 1996. PMID: 8825458

4

Costs, effects, and savings of screening for cystic fibrosis gene carriers.

Wildhagen MF, Hilderink HB, Verzijl JG, Verheij JB, Kooij L, Tijmstra T, ten Kate LP, Habbema JD. Wildhagen MF, et al. J Epidemiol Community Health. 1998 Jul;52(7):459-67. doi: 10.1136/jech.52.7.459. J Epidemiol Community Health. 1998. PMID: 9799881 Free PMC article.

5

Efficacy of cascade testing for fragile X syndrome.

Wildhagen MF, van Os TA, Polder JJ, ten Kate LP, Habbema JD. Wildhagen MF, et al. J Med Screen. 1999;6(2):70-6. doi: 10.1136/jms.6.2.70. J Med Screen. 1999. PMID: 10444723

6

[Serum screening in pregnant women for Down syndrome and open neural-tube defects; testing against the Health Council criteria for genetic screening].

Wildhagen MF, Christiaens GC, Habbema JD. Wildhagen MF, et al. Ned Tijdschr Geneeskd. 1996 Jan 13;140(2):85-9. Ned Tijdschr Geneeskd. 1996. PMID: 8569927 Dutch.

7

The nonhospital costs of care of patients with CF in The Netherlands: results of a questionnaire.

Wildhagen MF, Verheij JB, Verzijl JG, Gerritsen J, Bakker W, Hilderink HB, ten Kate LP, Tijmstra T, Kooij L, Habbema JD. Wildhagen MF, et al. Eur Respir J. 1996 Nov;9(11):2215-9. doi: 10.1183/09031936.96.09112215. Eur Respir J. 1996. PMID: 8947062 Free article.

8

[Preconception screening of parents and carrier state of cystic fibrosis in the Netherlands: expenses and savings].

Verheij JB, Hilderink HB, Verzijl JG, Wildhagen MF, Habbema JD, ten Kate LP. Verheij JB, et al. Among authors: wildhagen mf. Ned Tijdschr Geneeskd. 1998 Mar 28;142(13):706-10. Ned Tijdschr Geneeskd. 1998. PMID: 9623144 Dutch.

9

Explorative study of costs, effects and savings of screening for female fragile X premutation and full mutation carriers in the general population.

Wildhagen MF, van Os TA, Polder JJ, ten Kate LP, Habbema JD. Wildhagen MF, et al. Community Genet. 1998;1(1):36-47. doi: 10.1159/000016133. Community Genet. 1998. PMID: 15178985

10

Preconceptional screening of couples for carriers of cystic fibrosis: a prospective evaluation of effects, costs and savings for different mutation detection methods.

Verheij JB, Wildhagen MF, Hofstra RM, Pals G, Habbema JD, ten Kate LP. Verheij JB, et al. Among authors: wildhagen mf. Community Genet. 1999;2(2-3):74-81. doi: 10.1159/000016190. Community Genet. 1999. PMID: 15181337

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters